Overview
Nabla is a clinical AI layer for documentation and care-delivery workflows.
What Nabla does
Nabla provides clinical AI for health systems and healthcare product teams. Its ambient documentation captures the clinician-patient conversation and generates structured notes, with dictation and coding support integrated into clinical workflows.
Clinicians can tailor notes to their specialty and preferences. Coding suggestions draw on the documented encounter, with the clinician retaining the final decision. Integrations include Epic and athenahealth, while Nabla Connect and an API allow partners to embed the capabilities into their own applications.
Enterprise deployments include implementation and adoption support, along with configurable retention policies and governance. Nabla’s model combines documentation with the surrounding clinical workflow so the note, dictation and coding assistance can be used in the same care environment.
Pricing
Nabla publishes monthly individual subscriptions separately from organization-wide deployments.
- Individual subscription
- US$119 / month
- Per individual user, following a 30-day free trial. Group rates are offered separately.
Company details
- Funding
- $70M Series C announced June 17, 2025; $120M total raised at that announcement
Founders & leadership
Investors & backers
Nabla announced a $70M Series C led by HV Capital on June 17, 2025, bringing total funding to $120M.
- HV Capital
- Highland Europe
- DST Global
- Cathay Innovation
- Build Collective
